954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent adenovirus - Richard Casey; Wenliang Dong; Tereza Brachtlova; Allan Abramovitch; Jonathan Giddens; Peter Incze; Kenneth Jansz; Victor van Beusechem (Journal for ImmunoTherapy of Cancer, 2021)